1998
DOI: 10.1006/jsre.1998.5486
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-10 Inhibits Postinjury Tumor Necrosis Factor-Mediated Human Vascular Smooth Muscle Proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
1

Year Published

2001
2001
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(25 citation statements)
references
References 30 publications
0
24
1
Order By: Relevance
“…NO molecule and two anti-inflammatory cytokines, IL-10 and TGF-β, have potent anti-inflammatory effects on vascular cells [13,14,15,16]. Although in this study both IL-10 and TGF-β mRNA expressions were significantly higher in the injured LCA of group 1 and 2 animals compared to those in group 3, their expressions did not fluctuate significantly over time in both groups 1 and 2 following surgery (fig.…”
Section: Discussioncontrasting
confidence: 44%
See 1 more Smart Citation
“…NO molecule and two anti-inflammatory cytokines, IL-10 and TGF-β, have potent anti-inflammatory effects on vascular cells [13,14,15,16]. Although in this study both IL-10 and TGF-β mRNA expressions were significantly higher in the injured LCA of group 1 and 2 animals compared to those in group 3, their expressions did not fluctuate significantly over time in both groups 1 and 2 following surgery (fig.…”
Section: Discussioncontrasting
confidence: 44%
“…Moreover, experimental studies have previously shown that CD40 ligand [10] and interleukin (IL)-18 [11], two key proinflammatory mediators, and connexin 43 (Cx43) [12] directly participate in neointimal and smooth muscle cell (SMC) proliferation, which in turn cause vessel wall thickening and narrowing. Conversely, two antiproinflammatory cytokines, IL-10 [13] and transforming growth factor (TGF)-β [14], as well as nitric oxide (NO) molecule [15], are known to inhibit cytokine expression in vascular cells [13,14,15,16]. These results [10,11,12,13,14,15,16] further underscore the possible causal relationship between the inflammatory response cascade and atherosclerotic plaque formation, suggesting that broad-spectral inhibition of various inflammatory pathways may be required in preventing postinjury vascular proliferation rather than blocking merely one specific inflammatory mediator.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the effects of IL-10 on vascular cells may vary according to the origin of the cells and the signaling pathways induced by the proinflammatory stimuli. Accordingly, in other studies it was found that IL-10 downregulates the expression of ICAM-1 and VCAM-1 on IL-1-activated HUVECs, 25 decreases both IL-8 and IL-6 production by irradiated HUVECs, 26 inhibits TNF-induced or fibroblast growth factor-2 (FGF-2)-induced human aortic SMC proliferation, 27 and partially antagonizes IFN-␥-induced expression of the secretory nonpancreatic phospholipase A 2 in human SMCs. 28 Moreover, pretreatment of human aortic ECs with recombinant IL-10 as well as transfection with an adenovirus expressing viral IL-10 causes a significant decrease in minimally modified LDL-induced monocyte binding.…”
Section: Il-10mentioning
confidence: 94%
“…Moreover, TNF-α stimulates VSMC migration, one of the key processes of vascular stenotic lesion formation [29]. It was also shown that TNF-α may stimulate proliferation of VSMC [30] and enhance VSMC proliferation induced by monocytes [31], which is important for neointima growth and vessel remodeling. Finally, TNF-α was shown to be a key transcriptional inducer of several MMPs [32, 33], active participants of arterial response to intravascular injury promoting VSMC migration and replication [34, 35].…”
Section: Discussionmentioning
confidence: 99%